Emerging World Pharma Stock Analysis
| EWPI Stock | USD 0.0001 0.00 0.00% |
Emerging World's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Emerging World's financial risk is the risk to Emerging World stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Emerging World's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Emerging World is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Emerging World to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Emerging World is said to be less leveraged. If creditors hold a majority of Emerging World's assets, the Company is said to be highly leveraged.
Emerging World Pharma is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Emerging World stock analysis is to determine its intrinsic value, which is an estimate of what Emerging World Pharma is worth, separate from its market price. There are two main types of Emerging World's stock analysis: fundamental analysis and technical analysis.
The Emerging World stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Emerging World's ongoing operational relationships across important fundamental and technical indicators.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Emerging World Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Emerging Stock Analysis Notes
The company recorded a loss per share of 0.0. Emerging World Pharma had not issued any dividends in recent years. The entity had 1:25 split on the 24th of November 2009. Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations. The company was founded in 1997 and is based in Sunyani, Ghana. Emerging World is traded on OTC Exchange in the United States. To learn more about Emerging World Pharma call the company at 703-334-8453 or check out http://www.emergingpharma.com.Emerging World Pharma Investment Alerts
| Emerging World generated a negative expected return over the last 90 days | |
| Emerging World has some characteristics of a very speculative penny stock | |
| Emerging World has high likelihood to experience some financial distress in the next 2 years | |
| Emerging World Pharma currently holds 3.2 M in liabilities. Emerging World Pharma has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Emerging World's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (410.32 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Emerging World Pharma currently holds about 118.42 K in cash with (138.59 K) of positive cash flow from operations. |
Emerging Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 11.9 K.Technical Drivers
Emerging World Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Emerging World Pharma Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Emerging World price series with the more recent values given greater weights.
Emerging World Financial Rating
Emerging World Pharma financial ratings play a critical role in determining how much Emerging World have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Emerging World's borrowing costs.| Beneish M Score | (4.38) | Unlikely Manipulator | View |
Emerging World Pharma Debt to Cash Allocation
As Emerging World Pharma follows its natural business cycle, the capital allocation decisions will not magically go away. Emerging World's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Emerging World Pharma currently holds 3.2 M in liabilities. Emerging World Pharma has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Emerging World's use of debt, we should always consider it together with its cash and equity.Emerging World Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Emerging World's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Emerging World, which in turn will lower the firm's financial flexibility.About Emerging Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Emerging World prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Emerging shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Emerging World. By using and applying Emerging Stock analysis, traders can create a robust methodology for identifying Emerging entry and exit points for their positions.
Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations. The company was founded in 1997 and is based in Sunyani, Ghana. Emerging World is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Emerging World to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Complementary Tools for Emerging Stock analysis
When running Emerging World's price analysis, check to measure Emerging World's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emerging World is operating at the current time. Most of Emerging World's value examination focuses on studying past and present price action to predict the probability of Emerging World's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emerging World's price. Additionally, you may evaluate how the addition of Emerging World to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |